Primary Recommendation

Craneware - Billing software firm enjoying quick-fire growth

February 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

AIM-listed Craneware, which supplies billing and auditing software to help US hospitals improve their financial performance, has wasted little time in burnishing its growth stock credentials. The drive for increased efficiencies, as well as heavy regulatory pressures have effectively forced these hospitals to look to the private sector and Craneware has been perfectly placed to benefit, with revenues rising from US$10.5m in 2005 to US$23m in 2009, while pretax profit increased from US$2.7m to US$5.9m. This growth is all the more impressive because Craneware doesn't follow the traditional software model of selling a licence for a large upfront gain but instead rents the structure on five-year contracts with fees conservatively boo ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Dechra Pharmaceuticals - US launch of Vetoryl to boost profits

JD Sports

Craneware (September 2013)

Craneware (November 2012)

Craneware - Second downgrade this year (August 2012)

Craneware (March 2012)

Craneware (November 2011)

Craneware - New contract wins (September 2011)

Craneware - Acquistion raises forecasts (April 2011)

Craneware - Another amazing share price spike (December 2010)

Craneware - Shares spike vertically by over Â£1 (October 2010)

Craneware (June 2010)

Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X